Cargando…
Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing
BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) is one of the most common opportunistic infections in immunocompromised patients. However, the accurate prediction of the development of PJP in non-HIV immunocompromised patients is still unclear. METHODS: Non-HIV immunocompromised patients confirme...
Autores principales: | Huang, Liping, Xu, Shuyun, Huang, Zhimin, Chen, Yusheng, Xu, Nengluan, Xie, Baosong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951498/ https://www.ncbi.nlm.nih.gov/pubmed/36829171 http://dx.doi.org/10.1186/s12890-022-02300-8 |
Ejemplares similares
-
Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
por: Wang, Dongsheng, et al.
Publicado: (2022) -
Pneumocystis Jirovecii Pneumonia Diagnosis via Metagenomic Next-Generation Sequencing
por: Lu, Xiaoxiao, et al.
Publicado: (2022) -
Diagnostic performance of metagenomic next-generation sequencing for Pneumocystis jirovecii pneumonia
por: Li, Xuefang, et al.
Publicado: (2023) -
Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii Pneumonia in critically pediatric patients
por: Chen, Hengxin, et al.
Publicado: (2023) -
The diagnostic value of metagenomic next-generation sequencing for identifying Pneumocystis jirovecii infection in non-HIV immunocompromised patients
por: Zhao, Mengyi, et al.
Publicado: (2022)